• 152. Back to Basics - High Volume Metastatic Prostate Cancer

  • Apr 5 2025
  • Length: 24 mins
  • Podcast

152. Back to Basics - High Volume Metastatic Prostate Cancer

Listen for free

View show details

  • Summary

  • Today, we discuss the role of triplet therapy (ie, chemotherapy and androgen receptor signalling inhibitor and ADT) in high-volume metastatic hormone-sensitive prostate cancer and whether darolutamide is equivalent to the other androgen receptor signalling inhibitors in the castrate-sensitive space. Two good trials, and as always, some interesting discussion points.


    Studies discussed in the episode:

    ARASENS

    ARANOTE


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.







    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
Show More Show Less

What listeners say about 152. Back to Basics - High Volume Metastatic Prostate Cancer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available